Fulminant hepatic failure resulting from small-cell lung cancer and dramatic response of chemotherapy.

Abstract

Prompt treatment in tumor-associated encephalopathy may prolong survival. We describe a 69-year-old male patient who was presented with fulminant hepatic failure, secondary to small-cell lung carcinoma with rapidly progressing encephalopathy. Both symptoms remitted following chemotherapy, suggesting swift diagnosis and administration of chemotherapy to be effective in treatment of fulminant hepatic failure and encephalopathy.

• Authors: Kyoichi Kaira, Atsushi Takise, Rieko Watanabe, Masatomo Mori
• Journal: World journal of gastroenterology (World J Gastroenterol) Vol. 12 Issue 15 Pg. 2466-8 (Apr 21 2006) ISSN: 1007-9327 [Print] United States
• PMID: 16688847 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antineoplastic Agents

Topics

• Aged
• Antineoplastic Agents (therapeutic use)
• Carcinoma, Small Cell (complications, drug therapy, secondary)
• Humans
• Liver Failure, Acute (drug therapy, etiology)
• Liver Neoplasms (secondary)
• Lung Neoplasms (complications, drug therapy)
• Male